Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity

References

• Abdelghany SM, Quinn DJ, Ingram RJ, Gilmore BF, Donnelly RF, Taggart CC, Scott CJ. Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomed, 2012;7:4053–63
   PubMed Web of Science ®Google Scholar
• Asadi A. Streptomycin-loaded PLGA-alginate nanoparticles: Preparation, characterization, and assessment. Appl Nanosci, 2013;1–6
   Google Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm, 1999;25:471–6
   PubMed Web of Science ®Google Scholar
• Bilati U, Allemann E, Doelker E. Poly(d,l-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method – Processing and formulation issues for enhanced entrapment efficiency. J Microencapsul, 2005;22:205–14
   PubMed Web of Science ®Google Scholar
• Blanco D, Alonso MJ. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: Effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur J Pharm Biopharm, 1998;45:285–94
   PubMed Web of Science ®Google Scholar
• Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol, 1996;48:1147–52
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 2001;13:123–33
   PubMed Web of Science ®Google Scholar
• Cun D, Foged C, Yang M, Frokjaer S, Nielsen HM. Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm, 2010;390:70–5
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release, 2012;161:505–22
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53–69
   PubMed Web of Science ®Google Scholar
• Fiegel J, Ehrhardt C, Schaefer UF, Lehr CM, Hanes J. Large porous particle impingement on lung epithelial cell monolayers--toward improved particle characterization in the lung. Pharm Res, 2003;20:788–96
   PubMed Web of Science ®Google Scholar
• Florea BI, Cassara ML, Junginger HE, Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release, 2003;87:131–8
   PubMed Web of Science ®Google Scholar
• Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol, 2000;5:3–22
   PubMed Web of Science ®Google Scholar
• Gao H, Jones M-C, Chen J, Liang Y, Prud'homme RE, Leroux J-C. Hydrophilic nanoreservoirs embedded into polymeric micro/nanoparticles: An approach to compatibilize polar molecules with hydrophobic matrixes. Chem Mater, 2008;20:4191–3
   Google Scholar
• Gao P, Nie X, Zou M, Shi Y, Cheng G. Recent advances in materials for extended-release antibiotic delivery system. J Antibiot (Tokyo), 2011;64:625–34
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine, 2010;6:324–33
   PubMed Web of Science ®Google Scholar
• Honeybourne D. Antibiotic penetration into lung tissues. Thorax, 1994;49:104–6
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Tripartite Guideline. Stability testing of new drug substances and products. Q1A (R2); February 2003
   Google Scholar
• Ito F, Fujimori H, Makino K. Factors affecting the loading efficiency of water-soluble drugs in PLGA microspheres. Colloids Surf B Biointerfaces, 2008;61:25–9
   PubMed Web of Science ®Google Scholar
• Jeffery H, Davis SS, O'hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res, 1993;10:362–8
   PubMed Web of Science ®Google Scholar
• Kapus A, Szaszi K. Coupling between apical and paracellular transport processes. Biochem Cell Biol, 2006;84:870–80
   PubMedGoogle Scholar
• Karlowsky JA, Zhanel GG, Davidson RJ, Hoban DJ. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro. J Antimicrob Chemother, 1994;33:937–47
   PubMed Web of Science ®Google Scholar
• Knowles MR, Robinson JM, Wood RE, Pue CA, Mentz WM, Wager GC, Gatzy JT, Boucher RC. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Invest, 1997;100:2588–95
   PubMed Web of Science ®Google Scholar
• Kuhn RJ. Formulation of aerosolized therapeutics. Chest, 2001;120:94S–8S
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces, 2010;75:1–18
   PubMed Web of Science ®Google Scholar
• Lalani J, Rathi M, Lalan M, Misra A. Protein functionalized tramadol-loaded PLGA nanoparticles: Preparation, optimization, stability and pharmacodynamic studies. Drug Dev Ind Pharm, 2013;39:854–64
   PubMed Web of Science ®Google Scholar
• Lecaroz MC, Blanco-Prieto MJ, Campanero MA, Salman H, Gamazo C. Poly(D,L-lactide-coglycolide) particles containing gentamicin: Pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice. Antimicrob Agents Chemother, 2007;51:1185–90
   PubMed Web of Science ®Google Scholar
• Li Y, Taulier N, Rauth AM, Wu XY. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharm Res, 2006;23:1877–87
   PubMed Web of Science ®Google Scholar
• Li Y, Wong HL, Shuhendler AJ, Rauth AM, Wu XY. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles. J Control Release, 2008;128:60–70
   PubMed Web of Science ®Google Scholar
• Lu E, Franzblau S, Onyuksel H, Popescu C. Preparation of aminoglycoside-loaded chitosan nanoparticles using dextran sulphate as a counterion. J Microencapsul, 2009;26:346–54
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125:193–209
   PubMed Web of Science ®Google Scholar
• Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G. PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm, 2006;325:172–9
   PubMed Web of Science ®Google Scholar
• Okada H. One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv Drug Deliv Rev, 1997;28:43–70
   PubMed Web of Science ®Google Scholar
• Patel B, Gupta V, Ahsan F. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin. J Control Release, 2012a;162:310–20
   PubMed Web of Science ®Google Scholar
• Patel D, Naik S, Misra A. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain. J Pharm Sci, 2012b;101:690–706
   PubMed Web of Science ®Google Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60:110–11
   PubMedGoogle Scholar
• Prayle A, Smyth AR. Aminoglycoside use in cystic fibrosis: Therapeutic strategies and toxicity. Curr Opin Pulm Med, 2010;16:604–10
   PubMed Web of Science ®Google Scholar
• Ratjen F, Brockhaus F, Angyalosi G. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review. J Cyst Fibros, 2009;8:361–9
   PubMed Web of Science ®Google Scholar
• Sanders NN, De Smedt SC, Van Rompaey E, Simoens P, De Baets F, Demeester J. Cystic fibrosis sputum: A barrier to the transport of nanospheres. Am J Respir Crit Care Med, 2000;162:1905–11
   PubMed Web of Science ®Google Scholar
• Saxena V, Sadoqi M, Shao J. Indocyanine green-loaded biodegradable nanoparticles: Preparation, physicochemical characterization and in vitro release. Int J Pharm, 2004;278:293–301
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Hou S, Xu F, Zhao R, He J, Cai Z, Li Y, Chen Q. Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm, 2008a;69:445–53
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q, Li Y, Hou S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm, 2008b;350:320–9
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001;70:1–20
   PubMed Web of Science ®Google Scholar
• Suk JS, Lai SK, Wang YY, Ensign LM, Zeitlin PL, Boyle MP, Hanes J. The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. Biomaterials, 2009;30:2591–7
   PubMed Web of Science ®Google Scholar
• Tewes F, Munnier E, Antoon B, Ngaboni Okassa L, Cohen-Jonathan S, Marchais H, Douziech-Eyrolles L, Souce M, Dubois P, Chourpa I. Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods. Eur J Pharm Biopharm, 2007;66:488–92
   PubMed Web of Science ®Google Scholar
• Ungaro F, D'angelo I, Coletta C, D'emmanuele Di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. J Control Release, 2012;157:149–59
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang R, Lu X, Lu W, Zhang C, Liang W. Pegylated phospholipids-based self-assembly with water-soluble drugs. Pharm Res, 2010;27:361–70
   PubMed Web of Science ®Google Scholar
• Wikler MA. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. 8th ed. Wayne, PA: CLSI; 2008
   Google Scholar
• Wong HL, Bendayan R, Rauth AM, Wu XY. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. J Control Release, 2006;116:275–84
   PubMed Web of Science ®Google Scholar
• Xiang-Gen W, Li-Na Y, Meng X, Hao-Ran J. Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis caused by Aspergillus fumigatus. J Pharm Sci, 2011;100:1745–59
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Vandervoort J, Ludwig A. Influence of process parameters of high-pressure emulsification method on the properties of pilocarpine-loaded nanoparticles. J Microencapsul, 2003;20:449–58
   PubMed Web of Science ®Google Scholar